About Syncoms
Simplify's Rating
Why Syncoms is rated
C
Rated C on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation
Industries
Data & AnalyticsEnterprise SoftwareAI & Machine Learning
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
United Kingdom
Founded
1982
Get referred to Syncoms
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q1 FY27 PAT rose 57.7% to ₹24.85 crore on 8% income growth.
- FY26 net profit climbed 55.5% to ₹764.38 crore.
- September 23, 2026 final dividend record date signals continuing cash generation.
What critics are saying
- August 8, 2026 resignations removed the MD, CFO, and founder simultaneously.
- Exports supplied 82.94% of sales, concentrating demand and currency exposure.
- Permanent employee turnover hit 28% in FY26, weakening execution continuity.
What makes Syncoms unique
- WHO-GMP and ISO 9001:2015 certification supports regulated pharmaceutical manufacturing.
- FY26 revenue reached ₹5,205.11 crore, powered by pharmaceuticals.
- September 2026 AGM advances Rahul Bankda as MD and Rinki Bankda as WTD.
Help us improve and share your feedback! Did you find this helpful?
Syncoms is Hiring for 10 Jobs on Simplify!
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs
About Syncoms
Simplify's Rating
Why Syncoms is rated
C
Rated C on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation
Industries
Data & AnalyticsEnterprise SoftwareAI & Machine Learning
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
United Kingdom
Founded
1982
Syncoms is Hiring for 10 Jobs on Simplify!
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs